TY - BOOK AU - Sant, M. AU - Allemani, C. AU - Tereanu, C. AU - Angelis, R. AU - Capocaccia, R. AU - Visser, O. PY - 2010 DA - 2010// TI - Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project ID - Sant2010 ER - TY - JOUR AU - McKelvey, E. M. AU - Gottlieb, J. A. AU - Wilson, H. E. AU - Haut, A. AU - Talley, R. W. AU - Stephens, R. PY - 1976 DA - 1976// TI - Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma JO - Cancer VL - 38 UR - https://doi.org/3.0.CO;2-I DO - 3.0.CO;2-I ID - McKelvey1976 ER - TY - JOUR AU - Coiffier, B. AU - Lepage, E. AU - Brière, J. AU - Herbrecht, R. AU - Tilly, H. AU - Bouabdallah, R. PY - 2002 DA - 2002// TI - CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa011795 DO - 10.1056/NEJMoa011795 ID - Coiffier2002 ER - TY - JOUR AU - Pfreundschuh, M. AU - Trümper, L. AU - Österborg, A. AU - Pettengell, R. AU - Trneny, M. AU - Imrie, K. PY - 2006 DA - 2006// TI - CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group JO - Lancet Oncol VL - 7 UR - https://doi.org/10.1016/S1470-2045(06)70664-7 DO - 10.1016/S1470-2045(06)70664-7 ID - Pfreundschuh2006 ER - TY - JOUR AU - Fitoussi, O. AU - Belhadj, K. AU - Mounier, N. AU - Parrens, M. AU - Tilly, H. AU - Salles, G. PY - 2011 DA - 2011// TI - Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA JO - Haematologica VL - 96 UR - https://doi.org/10.3324/haematol.2010.038109 DO - 10.3324/haematol.2010.038109 ID - Fitoussi2011 ER - TY - JOUR AU - Italiano, A. AU - Jardin, F. AU - Peyrade, F. AU - Saudes, L. AU - Tilly, H. AU - Thyss, A. PY - 2005 DA - 2005// TI - Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old JO - Haematologica VL - 90 ID - Italiano2005 ER - TY - JOUR AU - Habermann, T. M. AU - Weller, E. A. AU - Morrison, V. A. AU - Gascoyne, R. D. AU - Cassileth, P. A. AU - Cohn, J. B. PY - 2006 DA - 2006// TI - Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.05.1003 DO - 10.1200/JCO.2005.05.1003 ID - Habermann2006 ER - TY - JOUR AU - Pfreundschuh, M. AU - Schubert, J. AU - Ziepert, M. AU - Schmits, R. AU - Mohren, M. AU - Lengfelder, E. PY - 2008 DA - 2008// TI - Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) JO - Lancet Oncol VL - 9 UR - https://doi.org/10.1016/S1470-2045(08)70002-0 DO - 10.1016/S1470-2045(08)70002-0 ID - Pfreundschuh2008 ER - TY - JOUR AU - Epelbaum, R. AU - Faraggi, D. AU - Ben-Arie, Y. AU - Ben-Shahar, M. AU - Haim, N. AU - Ron, Y. PY - 1990 DA - 1990// TI - Survival of diffuse large cell lymphoma. a multivariate analysis including dose intensity variables JO - Cancer VL - 66 UR - https://doi.org/3.0.CO;2-T DO - 3.0.CO;2-T ID - Epelbaum1990 ER - TY - JOUR AU - Bosly, A. AU - Bron, D. AU - Hoof, A. AU - Bock, R. AU - Berneman, Z. AU - Ferrant, A. PY - 2008 DA - 2008// TI - Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP JO - Ann Hematol VL - 87 UR - https://doi.org/10.1007/s00277-007-0399-y DO - 10.1007/s00277-007-0399-y ID - Bosly2008 ER - TY - JOUR AU - Lepage, E. AU - Gisselbrecht, C. AU - Haioun, C. AU - Sebban, C. AU - Tilly, H. AU - Bosly, A. PY - 1993 DA - 1993// TI - Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol JO - Ann Oncol VL - 4 ID - Lepage1993 ER - TY - JOUR AU - Pettengell, R. AU - Schwenkglenks, M. AU - Bosly, A. PY - 2008 DA - 2008// TI - Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy JO - Ann Hematol VL - 87 UR - https://doi.org/10.1007/s00277-008-0447-2 DO - 10.1007/s00277-008-0447-2 ID - Pettengell2008 ER - TY - JOUR AU - Terada, Y. AU - Nakamae, H. AU - Aimoto, R. AU - Kanashima, H. AU - Sakamoto, E. AU - Aimoto, M. PY - 2009 DA - 2009// TI - Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma JO - J Exp Clin Cancer Res VL - 28 UR - https://doi.org/10.1186/1756-9966-28-116 DO - 10.1186/1756-9966-28-116 ID - Terada2009 ER - TY - JOUR AU - Hirakawa, T. AU - Yamaguchi, H. AU - Yokose, N. AU - Gomi, S. AU - Inokuchi, K. AU - Dan, K. PY - 2010 DA - 2010// TI - Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma JO - Ann Hematol VL - 89 UR - https://doi.org/10.1007/s00277-010-0956-7 DO - 10.1007/s00277-010-0956-7 ID - Hirakawa2010 ER - TY - JOUR AU - Epelbaum, R. AU - Haim, N. AU - Ben-Shahar, M. AU - Ron, Y. AU - Cohen, Y. PY - 1988 DA - 1988// TI - Dose-intensity analysis for CHOP chemotherapy in diffuse aggressive large cell lymphoma JO - Isr J Med Sci VL - 24 ID - Epelbaum1988 ER - TY - JOUR AU - Kwak, L. W. AU - Halpern, J. AU - Olshen, R. A. AU - Horning, S. J. PY - 1990 DA - 1990// TI - Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis JO - J Clin Oncol VL - 8 ID - Kwak1990 ER - TY - STD TI - Wildiers H, Reiser M. Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma. Crit Rev Oncology/Hematology. 2011;77(3):221–40. http://dx.doi.org/10.1016/j.critrevonc.2010.02.002. ID - ref17 ER - TY - JOUR AU - Roswall, N. AU - Olsen, A. AU - Christensen, J. AU - Rugbjerg, K. AU - Mellemkjær, L. PY - 2008 DA - 2008// TI - Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994–2003 JO - Eur J Cancer VL - 44 UR - https://doi.org/10.1016/j.ejca.2008.06.011 DO - 10.1016/j.ejca.2008.06.011 ID - Roswall2008 ER - TY - JOUR AU - Cronin-Fenton, D. P. AU - Sharp, L. AU - Deady, S. AU - Comber, H. PY - 2006 DA - 2006// TI - Treatment and survival for non-Hodgkin’s lymphoma: Influence of histological subtype, age, and other factors in a population-based study (1999–2001) JO - Eur J Cancer VL - 42 UR - https://doi.org/10.1016/j.ejca.2006.04.018 DO - 10.1016/j.ejca.2006.04.018 ID - Cronin-Fenton2006 ER - TY - JOUR AU - Frederiksen, B. L. AU - Dalton, S. O. AU - Osler, M. AU - Steding-Jessen, M. AU - Nully, B. P. PY - 2012 DA - 2012// TI - Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark - a nationwide study JO - Br J Cancer VL - 106 UR - https://doi.org/10.1038/bjc.2012.3 DO - 10.1038/bjc.2012.3 ID - Frederiksen2012 ER - TY - JOUR AU - Tao, L. AU - Foran, J. M. AU - Clarke, C. A. AU - Gomez, S. L. AU - Keegan, T. H. M. PY - 2014 DA - 2014// TI - Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-07-517110 DO - 10.1182/blood-2013-07-517110 ID - Tao2014 ER - TY - JOUR AU - Loberiza, F. R. AU - Cannon, A. J. AU - Weisenburger, D. D. AU - Vose, J. M. AU - Moehr, M. J. AU - Bast, M. A. PY - 2009 DA - 2009// TI - Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.22.0038 DO - 10.1200/JCO.2009.22.0038 ID - Loberiza2009 ER - TY - STD TI - 23. Pornet C, Delpierre C, Dejardin O, Grosclaude P, Launay L, Guittet L et al. Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Community Health. 2012. doi:10.1136/jech-2011-200311. ID - ref23 ER - TY - JOUR AU - Oken, M. M. AU - Creech, R. H. AU - Tormey, D. C. AU - Horton, J. AU - Davis, T. E. AU - McFadden, E. T. PY - 1982 DA - 1982// TI - Toxicity and response criteria of the Eastern Cooperative Oncology Group JO - Am J Clin Oncol VL - 5 UR - https://doi.org/10.1097/00000421-198212000-00014 DO - 10.1097/00000421-198212000-00014 ID - Oken1982 ER - TY - JOUR AU - Blay, J. Y. AU - Gomez, F. AU - Sebban, C. AU - Bachelot, T. AU - Biron, P. AU - Guglielmi, C. PY - 1998 DA - 1998// TI - The international prognostic index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial JO - Blood VL - 92 ID - Blay1998 ER - TY - JOUR PY - 1993 DA - 1993// TI - A predictive model for aggressive Non-Hodgkin's lymphoma JO - N Engl J Med VL - 329 UR - https://doi.org/10.1056/NEJM199309303291402 DO - 10.1056/NEJM199309303291402 ID - ref26 ER - TY - JOUR AU - Sehn, L. H. AU - Berry, B. AU - Chhanabhai, M. AU - Fitzgerald, C. AU - Gill, K. AU - Hoskins, P. PY - 2007 DA - 2007// TI - The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-08-038257 DO - 10.1182/blood-2006-08-038257 ID - Sehn2007 ER - TY - JOUR AU - Peyrade, F. AU - Jardin, F. AU - Thieblemont, C. AU - Thyss, A. AU - Emile, J. -. F. AU - Castaigne, S. PY - 2011 DA - 2011// TI - Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70069-9 DO - 10.1016/S1470-2045(11)70069-9 ID - Peyrade2011 ER - TY - JOUR AU - Lyman, G. H. AU - Dale, D. C. AU - Friedberg, J. AU - Crawford, J. AU - Fisher, R. I. PY - 2004 DA - 2004// TI - Incidence and predictors of Low chemotherapy dose-intensity in aggressive Non-Hodgkin's lymphoma: a nationwide study JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.03.213 DO - 10.1200/JCO.2004.03.213 ID - Lyman2004 ER - TY - JOUR AU - Bonadonna, G. AU - Valagussa, P. PY - 1981 DA - 1981// TI - Dose–response effect of adjuvant chemotherapy in breast cancer JO - N Engl J Med VL - 304 UR - https://doi.org/10.1056/NEJM198101013040103 DO - 10.1056/NEJM198101013040103 ID - Bonadonna1981 ER - TY - JOUR AU - Hryniuk, W. AU - Bush, H. PY - 1984 DA - 1984// TI - The importance of dose intensity in chemotherapy of metastatic breast cancer JO - J Clin Oncol VL - 2 ID - Hryniuk1984 ER - TY - JOUR AU - Green, J. A. AU - Dawson, A. A. AU - Fell, L. F. AU - Murray, S. PY - 1980 DA - 1980// TI - Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease JO - Br J Clin Pharmacol VL - 9 UR - https://doi.org/10.1111/j.1365-2125.1980.tb05847.x DO - 10.1111/j.1365-2125.1980.tb05847.x ID - Green1980 ER - TY - JOUR AU - Berben, L. AU - Dobbels, F. AU - Engberg, S. AU - Hill, M. N. AU - Geest, S. PY - 2012 DA - 2012// TI - An ecological perspective on medication adherence JO - West J Nurs Res VL - 34 UR - https://doi.org/10.1177/0193945911434518 DO - 10.1177/0193945911434518 ID - Berben2012 ER - TY - JOUR AU - Compaci, G. AU - Ysebaert, L. AU - Obéric, L. AU - Derumeaux, H. AU - Laurent, G. PY - 2011 DA - 2011// TI - Effectiveness of telephone support during chemotherapy in patients with diffuse large B cell lymphoma: the ambulatory medical assistance (AMA) experience JO - Int J Nurs Stud VL - 48 UR - https://doi.org/10.1016/j.ijnurstu.2011.01.008 DO - 10.1016/j.ijnurstu.2011.01.008 ID - Compaci2011 ER - TY - JOUR AU - Noens, L. AU - Lierde, M. A. AU - Bock, R. AU - Verhoef, G. AU - Zachee, P. AU - Berneman, Z. PY - 2009 DA - 2009// TI - Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-12-196543 DO - 10.1182/blood-2008-12-196543 ID - Noens2009 ER - TY - JOUR AU - Despas, F. AU - Roche, H. AU - Laurent, G. PY - 2013 DA - 2013// TI - [Anticancer drug adherence] JO - Bull Cancer VL - 100 ID - Despas2013 ER - TY - JOUR AU - Schleifer, S. J. AU - Bhardwaj, S. AU - Lebovits, A. AU - Tanaka, J. S. AU - Messe, M. AU - Strain, J. J. PY - 1991 DA - 1991// TI - Predictors of physician nonadherence to chemotherapy regimens JO - Cancer VL - 67 UR - https://doi.org/3.0.CO;2-R DO - 3.0.CO;2-R ID - Schleifer1991 ER - TY - JOUR AU - Yamaguchi, H. AU - Hirakawa, T. AU - Inokuchi, K. PY - 2011 DA - 2011// TI - Importance of relative dose intensity in chemotherapy for diffuse large B-cell lymphoma JO - J Clin Exp Hematop VL - 51 UR - https://doi.org/10.3960/jslrt.51.1 DO - 10.3960/jslrt.51.1 ID - Yamaguchi2011 ER - TY - STD TI - 39. Maurer MJ, Ghesquières H, Jais J-P, Witzig TE, Haioun C, Thompson CA et al. Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy. J Clin Oncol. 2014. doi:10.1200/jco.2013.51.5866. ID - ref39 ER - TY - JOUR AU - Lee, B. AU - Goktepe, O. AU - Hay, K. AU - Connors, J. M. AU - Sehn, L. H. AU - Savage, K. J. PY - 2014 DA - 2014// TI - Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia JO - Oncologist VL - 19 UR - https://doi.org/10.1634/theoncologist.2013-0343 DO - 10.1634/theoncologist.2013-0343 ID - Lee2014 ER - TY - JOUR AU - Dejardin, O. AU - Berchi, C. AU - Mignon, A. AU - Pornet, C. AU - Guillaume, E. AU - Guittet, L. PY - 2011 DA - 2011// TI - Inégalités sociales, de santé du constat à l’action – Intérêt de la mise en place d’un accompagnement personnalisé pour la réduction des inégalités sociales en cancérologie JO - Rev Epidemiol Sante Publique VL - 59 UR - https://doi.org/10.1016/j.respe.2010.10.008 DO - 10.1016/j.respe.2010.10.008 ID - Dejardin2011 ER - TY - JOUR AU - Pornet, C. AU - Dejardin, O. AU - Morlais, F. AU - Bouvier, V. AU - Launoy, G. PY - 2010 DA - 2010// TI - Socioeconomic determinants for compliance to colorectal cancer screening. a multilevel analysis JO - J Epidemiol Community Health VL - 64 UR - https://doi.org/10.1136/jech.2008.081117 DO - 10.1136/jech.2008.081117 ID - Pornet2010 ER -